Review Article

A Systematic Review for Anti-Inflammatory Property of Clusiaceae Family: A Preclinical Approach

Table 1

Description of the anti-inflammatory aspects of the studies included in systematic review.

ReferencesScientific nameParts used AnimalDoseRouteMethods usedAction mechanism

Trovato et al., 2001 [11]H. empetrifolium APMEWistar rats100 mg/kgi.p.CIPEInhibition of PG
Ozturk et al., 2002 [12]H. triquetrifolium DAPEWistar rats25–60 mg/kgi.p.CIPEWithout mechanism
Rabanal et al., 2005 [13]H. canariense; H. glandulosum BMESwiss mice 0.25–1 mg/eart.a.TPAIEEInhibition of AA metabolism
Abdel-Salam 2005 [14]H. perforatum Commercial extractSprague-Dawley rats50–300 mg/kgs.c.CIPEInhibition of the liberation of HIS, 5-HT, KN
Sánchez-Mateo et al., 2006 [15]H. reflexum BMESwiss mice0.25–1 mg/eart.a.TPAIEEInhibition of PLA2, COX, and LOX
Nguemfo et al., 2007 [16]A. monticola SBMCMEWistar rats75–300 mg/kgp.o.CIPE; HSIPE; AAIPE; DIPEInhibition of AA metabolism
Šavikin et al., 2007 [17]H. perforatum; H. barbatum; H. hirsutum; H. richeri; H. androsaemum. DAPEWistar rats25–200 mg/kgp.o.CIPEInhibition of NF- B.
Frutuoso et al., 2007 [18]R. longifolia LAESwiss mice; Wistar rats10–100 mg/kgp.o.PILPSInhibition of neutrophil
Ymele et al., 2013 [19]A. gabonensis SBAEWistar rats100–400 mg/kgp.o.CIPE; HSIPEReduced liberation and action of His and 5-HT;
inhibition AA metabolism
Šavikin et al., 2007 [17]H. perforatum; H. barbatum; H. hirsutum; H. richeri; H. androsaemum. DAPEWistar rats25–200 mg/kgp.o.CIPEInhibition of NF- B.
Panthong et al., 2007 [20]G. hanburyi BEAESprague-Dawley rats10–40 mg/kgp.o.EPPIEE; CIPE; AAIPE; GGICPInhibition of the liberation of His, PG, KN
Castardo et al., 2008 [21]G. gardneriana LHESwiss mice30–300 mg/kgi.p.CIPE; HSIPE; TPAIPE; BKIPE; AAIPE MPOAA; SPIPEInhibition of the activity of neuropeptides and PKC
Galati et al., 2008 [22]H. rumeliacum APMEWistar rats50; 70 mg/kgi.p.CIPEWithout mechanism
Martins et al., 2008 [23]G. brasiliensis FPOWistar rats100 mg/kgp.o.CIPEWithout mechanism
dos Reis et al., 2009 [24]G. cambogia FPEWistar rats 0.5; 1.0 g/kgp.o.CITNBS; MPOAA; EMPGE2Inhibition COX-2 expression and production of PGE2
Zdunić et al., 2009 [25]H. perforatum FTOEWistar rats1.25 mL/Kgp.o.CIPEWithout mechanism
Paterniti et al., 2010 [26]H. Perforatum MESprague-Dawley rats2 mg/kgPIL; MPOAA; MVP; CEReduces the NF- B translocation; inhibition the I B- degradation; attenuation of the expression of iNOS
S ntar et al., 2010 [27]H. perforatum APOOE; APEESprague-Dawley rats; Swiss mice50–400 mg/kgp.o.AcAICPWithout mechanism
Otuki et al., 2011 [28]G. gardneriana LHE; BHE; SHESwiss Webster mice0.01–1 mg/eart.a.COIEE; MPOAAInflammatory signal transduction pathway not specified
Ozturk et al., 2011 [12]G. brasiliensis LEEWistar rats30–300 mg/kgp.o.CIPE; PILPS; GGICPInhibition of the liberation of His, 5-HT, and BK
Santos et al., 2011 [29]C. nemorosa LHxESwiss mice50–200 mg/kgi.p.CIP; MTP; MTNF- ; GGICPInhibition of the neutrophil migration

Abbreviations of parts used: APME: aerial parts methanol extract; APEE: aerial parts ethanolic extract; APOOE: aerial parts olive oil extract; BEAE: bark ethyl acetate extract; BHE: bark hydroalcoholic extract; BME: blossom methanol extract; DAPE: dried aerial parts extract; FPE: fruit peel extract; FPO: fruit pee oil; FTOE: flowering tops oil extracts; LAE: leaves aqueous extract; LHE: leaves hydroalcoholic extract; LEE: leaves ethanolic extract; LHxE: leaves hexanic extract; ME: methanolic extract; SBAE: stem bark aqueous extract; SBMCME: stem barks methylene chloride/methanol extract; SHE: seeds hydroalcoholic extract.
Abbreviations of administration routes: i.p.: intraperitoneal; p.o.: oral administration; t.a.: topical administration.
Abbreviations of methods used: AAIPE: arachidonic acid-induced paw edema; AcAICP: acetic acid-induced increase in capillary permeability; BKIPE: bradykinin induced paw edema; CE: cytokines expression; CIP: carrageenan-induced pleurisy; CIPE: carrageenan-induced paw edema; CITNBS: colitis induced by 2,4,6-trinitrobenzenesulfonic acid; DIPE; dextran-induced paw edema; COIEE: croton oil-induced ear edema; EMPGE2: evaluation of mucosal PGE2; EPPIEE: ethyl phenylpropiolate induced ear edema; GGICP: granulomatous growth induced by cotton pellet; HSIPE: histamine and serotonin induced paw edema; MPOAA: myeloperoxidase activity assay; MTNF- : measurement of tumor necrosis factor alpha; MTP: measurement of total protein; PEILPS: peritonitis induced by lipopolysaccharide; PIL: peritonitis induced by ligature; PILPS: pleurisy induced by LPS; SPIPE: substance P induced paw edema; TPAIPE: 12-O-tetradecanoylphorbol 13-acetate induced paw edema.
Abbreviations of action mechanism: AA: arachidonic acid; BK: bradykinin; COX: cyclooxygenase; His: histamine; iNOS: inducible nitric oxide synthase; KN: kinins; LOX: lipoxygenase; MVP: measurement of vascular permeability; NF- B: nuclear factor kappa B; PKC: protein kinase C; PLA2: phospholipase A2; PG: prostaglandin, 5-HT: 5-hydroxytryptamine.